Megan A. Clarke

ORCID: 0000-0003-0435-7376 · 4 papers in corpus
observational 2026
Cancer medicine ·doi:10.1002/cam4.72003

BACKGROUND: Most ovarian cancers are detected at advanced stages, with poor outcomes. Ovarian cancer is heterogeneous; the most common subtype, serous ovarian carcinoma, may originate outside of the ovaries. To inform etiologic heterogeneit…

observational 2020
Gynecologic Oncology ·doi:10.1016/j.ygyno.2019.09.014

OBJECTIVE: To evaluate endometrial cancer (EC) risk assessment and early detection strategies in high-risk populations, we designed a large, prospective cohort study of women undergoing endometrial evaluation to assess risk factors and coll…

meta-analysis 2020
Cancer causes & control : CCC ·doi:10.1007/s10552-020-01327-8

PURPOSE: The link between lipid-stabilizing medications and epithelial ovarian carcinogenesis is incompletely understood. Statins may reduce ovarian cancer risk, but results are inconclusive. METHODS: We conducted a systematic review and m…

other 2020
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2020.05.050